Crescendo Biologics is a biopharmaceutical company developing conditionally-activated T cell enhancing therapeutics, with a particular focus on CD137 (4-1BB). 

Biotechnology

Crescendo Biologics

Crescendo Biologics' headquarters in Cambridge, United Kingdom

Colette Johnston

Laurie Galson-Holt

Julia Pizzey

Daniela Sydoruk

Hardev Pandha

Kevin Johnson

Marietta Wu

Kerry Fisher

Igor Matushansky

Gilles Nobécourt

Larry Fong

Graziano Seghezzi

Craig Richardson

Ignacio Melero

Tania Watts

Johann de Bono

The Research & Development team at Crescendo Biologics is dedicated to advancing innovative biopharmaceuticals focused on enhancing T cell therapies, particularly through the modulation of CD137. This multidisciplinary team works on various stages of therapeutic development, including discovery, process development, and translational biology, to ensure the effective design, formulation, and clinical application of conditionally-activated T cell platforms. Their collaborative efforts aim to translate cutting-edge scientific discoveries into viable treatment options for patients.

Research & Development

The Leadership Team at Crescendo Biologics is responsible for setting the strategic vision and direction of the company, overseeing the development and commercialization of innovative T cell enhancing therapeutics. This team, comprised of senior executives in discovery, operations, clinical development, and manufacturing, collaborates to drive research initiatives, align resources, and ensure successful product development while fostering a culture of innovation and compliance within the biopharmaceutical landscape.

Leadership Team

Crescendo Biologics

Org chart

Board & advisors

Teams

Research & Development

Leadership Team

Offices

Crescendo Biologics

Org chart

Board & advisors

Teams

Research & Development

Leadership Team

Offices

Related companies